Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2010

Open Access 01-10-2010 | Original paper

Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?

Authors: Daixin Yin, Cyllene Morris, Mark Allen, Rosemary Cress, Janet Bates, Lihua Liu

Published in: Cancer Causes & Control | Issue 10/2010

Login to get access

Abstract

Objective

Very few studies have simultaneously examined incidence of the leading cancers in relation to socioeconomic status (SES) and race/ethnicity in populations including Hispanics and Asians. This study aims to describe SES disparity in cancer incidence within each of four major racial/ethnic groups (non-Hispanic white, black, Hispanic, and Asian/Pacific Islander) for five major cancer sites, including female breast cancer, colorectal cancer, cervical cancer, lung cancer, and prostate cancer.

Methods

Invasive cancers of the five major sites diagnosed from 1998 to 2002 (n = 376,158) in California were included in the study. Composite area-based SES measures were used to quantify SES level and to calculate cancer incidence rates stratified by SES. Relative index of inequality (RII) was generated to measure SES gradient of cancer incidence within each racial/ethnic group.

Results

Significant variations were detected in SES disparities across the racial/ethnic groups for all five major cancer sites. Female breast cancer and prostate cancer incidence increased with increased SES in all groups, with the trend strongest among Hispanics. Incidence of cervical cancer increased with decreased SES, with the largest gradient among non-Hispanic white women. Lung cancer incidence increased with decreased SES with the exception of Hispanic men and women, for whom SES gradient was in the opposite direction. For colorectal cancer, higher incidence was associated with lower SES in non-Hispanic whites but with higher SES in Hispanics and Asian/Pacific Islander women.

Conclusions

Examining SES disparity stratified by race/ethnicity enhances our understanding of the complex relationships between cancer incidence, SES, and race/ethnicity.
Literature
1.
Baquet CR, Horm JW, Gibbs T, Greenwald P (1991) Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83(8):551–557CrossRefPubMed
2.
Gorey KM, Vena JE (1994) Cancer differentials among US blacks and whites: quantitative estimates of socioeconomic-related risks. J Natl Med Assoc 86(3):209–215PubMed
3.
Devesa SS, Diamond EL (1983) Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol 118(6):818–831PubMed
4.
Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20(4):417–435CrossRefPubMed
5.
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18(1):121–131CrossRefPubMed
6.
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME (2008) An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992–2004. Am J Epidemiol 167(8):889–899CrossRefPubMed
7.
Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9(4):369–380CrossRefPubMed
8.
Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S et al (1999) Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988–92 (United States). Cancer Causes Control 10(6):525–537CrossRefPubMed
9.
Liu L, Cozen W, Bernstein L, Ross RK, Deapen D (2001) Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 93(9):705–709CrossRefPubMed
10.
Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711CrossRefPubMed
11.
Krieger N, Chen JT, Waterman PD, Rehkopf DH, Yin R, Coull BA (2006) Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978–2002 (United States). Cancer Causes Control 17(2):217–226CrossRefPubMed
12.
Singh GK MB, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. NCI Cancer Surveillance Monograph Series, Number 4. National Cancer Institute, Bethesda, MD. NIH Publication No. 03-5417
13.
Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, et al. (2009) Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control
14.
McDougall JA, Madeleine MM, Daling JR, Li CI (2007) Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992–2003. Cancer Causes Control 18(10):1175–1186CrossRefPubMed
15.
Kawachi I, Berkman L (2003) Neighborhoods and health. Oxford University Press, New YorkCrossRef
16.
Krieger N, Williams DR, Moss NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 18:341–378CrossRefPubMed
17.
Diez Roux AV (2001) Investigating neighborhood and area effects on health. Am J Public Health 91(11):1783–1789CrossRefPubMed
18.
Diez Roux AV (2004) The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 26:104–111CrossRefPubMed
19.
Pickett KE, Pearl M (2001) Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. J Epidemiol Commun Health 55(2):111–122CrossRef
20.
MacKinnon JA, Duncan RC, Huang Y, Lee DJ, Fleming LE, Voti L et al (2007) Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev 16(4):756–762CrossRefPubMed
21.
Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW (1998) Adjustment of cancer incidence rates for ethnic misclassification. Biometrics 54(2):774–781CrossRefPubMed
22.
Census 2000 Summary File 4 Technical Documentation (2003) U.S. Census Bureau
23.
Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9):1721–1728CrossRefPubMed
24.
Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V (2008) The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999–2004. Cancer 112(4):737–747CrossRefPubMed
25.
Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H (2007) Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16(3):546–552CrossRefPubMed
26.
Ou SH, Zell JA, Ziogas A, Anton-Culver H (2008) Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 112(9):2011–2020CrossRefPubMed
27.
Clarke CA, Glaser SL, Keegan TH, Stroup A (2005) Neighborhood socioeconomic status and Hodgkin’s lymphoma incidence in California. Cancer Epidemiol Biomarkers Prev 14(6):1441–1447CrossRefPubMed
28.
Parikh-Patel A, Bates JH, Campleman S (2006) Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988–2000. Cancer 107(5 Suppl):1189–1195CrossRefPubMed
29.
Census 2000 Summary File 1 (2001) U.S. Census Bureau
30.
Harper S, Lynch J (2005) Methods for measuring cancer disparities: using data relevant to healthy people 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series, Number 6. National Cancer Institute, Bethesda, MD. NIH Publication No. 05-5777
31.
Sergeant JC, Firth D (2006) Relative index of inequality: definition, estimation, and inference. Biostatistics 7(2):213–224CrossRefPubMed
32.
Wagstaff A, Paci P, van Doorslaer E (1991) On the measurement of inequalities in health. Soc Sci Med 33(5):545–557CrossRefPubMed
33.
Krieger N, Waterman PD, Chen JT, Rehkopf DH, Subramanian SV. Geocoding and monitoring US socioeconomic inequalities in health: an introduction to using area-based socioeconomic measures—The Public Health Disparities Geocoding Project monograph
34.
Rodriguez MA, Ward LM, Perez-Stable EJ (2005) Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med 3(3):235–241CrossRefPubMed
35.
Dye JL (2005) Fertility of American Women: June 2004. Current Population Reports, P20-555. U.S. Census Bureau Washington, DC
36.
Bachu A (1995) Fertility of American Women: June 1994, U.S. Bureau of the Census. Current Population Reports, P20-482, U.S. Government Printing Office, Washington, DC
37.
Census Bureau Public Use Microdata Sample 1 percent (PUMS 1%)—78% Hispanic in California were of Mexican origin and over 40% were foreign-born
38.
Lewis C, Ventura S (1990) Birth and fertility rates by education: 1980 and 1985. Vital and health statistics series 21, Data on natality, marriage, and divorce. 49:1–40
39.
Stoops N (2004) Educational attainment in the United States: 2003. Current population reports P20-550. U.S. Census Bureau
40.
Hoffman RM, Stone SN, Espey D, Potosky AL (2005) Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer 5:27CrossRefPubMed
41.
Coker AL, Sanderson M, Ellison GL, Fadden MK (2006) Stress, coping, social support, and prostate cancer risk among older African American and Caucasian men. Ethn Dis 16(4):978–987PubMed
42.
Nielsen NR, Kristensen TS, Zhang ZF, Strandberg-Larsen K, Schnohr P, Gronbaek M (2007) Sociodemographic status, stress, and risk of prostate cancer. A prospective cohort study. Ann Epidemiol 17(7):498–502CrossRefPubMed
43.
Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J et al (2009) Correlates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care 15(11):793–799PubMed
44.
Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057CrossRefPubMed
45.
Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31(3):157–181CrossRefPubMed
46.
Santelli JS, Lowry R, Brener ND, Robin L (2000) The association of sexual behaviors with socioeconomic status, family structure, and race/ethnicity among US adolescents. Am J Public Health 90(10):1582–1588CrossRefPubMed
47.
Wellings K, Field B (1996) Sexual behaviour in young people. Baillieres Clin Obstet Gynaecol 10(1):139–160CrossRefPubMed
48.
Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T (2009) Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 20(4):459–471CrossRefPubMed
49.
Bethel JW, Schenker MB (2005) Acculturation and smoking patterns among Hispanics: a review. Am J Prev Med 29(2):143–148CrossRefPubMed
50.
Navarro AM (1996) Cigarette smoking among adult Lations: The California Tobacco Baseline Survey. Ann Behav Med 18(4):238–245CrossRefPubMed
51.
Landrine H, Klonoff EA, Fernandez S, Hickman N, Kashima K, Parekh B et al (2005) Cigarette advertising in Black, Latino, and White magazines, 1998–2002: an exploratory investigation. Ethn Dis 15(1):63–67PubMed
52.
Akresh IR (2007) Dietary assimilation and health among hispanic immigrants to the United States. J Health Soc Behav 48(4):404–417CrossRefPubMed
53.
Ayala GX, Baquero B, Klinger S (2008) A systematic review of the relationship between acculturation and diet among Latinos in the United States: implications for future research. J Am Diet Assoc 108(8):1330–1344CrossRefPubMed
54.
Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ (1984) Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 120(6):834–851PubMed
55.
Pawson IG, Martorell R, Mendoza FE (1991) Prevalence of overweight and obesity in US Hispanic populations. Am J Clin Nutr 53(6 Suppl):1522S–1528SPubMed
56.
Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J (2005) Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp 20(1):18–25PubMed
57.
58.
Michels KB, Edward G, Joshipura KJ, Rosner BA, Stampfer MJ, Fuchs CS et al (2000) Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 92(21):1740–1752CrossRefPubMed
59.
Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L et al (2001) Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 93(7):525–533CrossRefPubMed
60.
61.
62.
Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMed
63.
Campbell PR (1996) Population projections for states by age, sex, race, and hispanic origin: 1995–2025. U.S. Bureau of the Census, Population Division, PPL-47
Metadata
Title
Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?
Authors
Daixin Yin
Cyllene Morris
Mark Allen
Rosemary Cress
Janet Bates
Lihua Liu
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9601-y

Other articles of this Issue 10/2010

Cancer Causes & Control 10/2010 Go to the issue

Letter to the editor

Vitamin and mineral use and risk of prostate cancer: misleading?

Original paper

A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program

Original paper

Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma

Original paper

Cancer risk in Norwegian world class athletes

Original paper

A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study

Original paper

Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits